Halovate-S Ointment
By Halovate-S
Rx
30gm Ointment in a Tube

Composition
Halobetasol(0.05% w/w) + Salicylic Acid(3% w/w)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
December, 2026

liver
Safety Advice - Liver It has been determined that there are no known interactions or established effects on the liver related to the use of Halovate-S Ointment. This means that there haven't been any reported issues specific to liver safety associated with this ointment. Consult with your doctor for proper guidance before using Halovate-S Ointment.

kidney
No interaction found or established with kidney issues for Halovate-S Ointment. Consult with your doctor for proper guidance before using Halovate-S Ointment.

alcohol
No interaction or risks identified regarding alcohol with Halovate-S Ointment. Stick to the prescribed safety advice during pregnancy.

driving
It is safe to drive while using Halovate-S Ointment as no interactions have been identified. Drive cautiously as usual.

pregnancy
Halovate-S Ointment may not be safe to use during pregnancy, as animal studies suggest possible harm to the baby. Consult your doctor for evaluation of benefits versus risks before using.

breastfeeding
Halovate-S Ointment is likely safe for breastfeeding, based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | DERMA |
Action Class | - |
₹399.12
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024